B
Bristol Myers Squibb
Transforming Patients' Lives Through Science
Princeton, NJ
34,000+
About Bristol Myers Squibb
Industry:
Pharmaceuticals
Founded:
1887
Founders:
Edward Robinson Squibb
Status:
Public (NYSE: BMY)
Funding & Growth
Total Raised:
N/A
Valuation:
$100B+ market cap
Stage:
Public
Key Investors:
Public markets
✓ Pros
- • Strong oncology portfolio
- • Good work-life balance
- • Multiple locations
- • Research investment
- • Stable company
✗ Cons
- • Large company bureaucracy
- • Recent acquisitions integration
- • Some locations remote
- • Traditional pharma culture